Dechra Pharmaceuticals PLC Opening of its solar power plant in Croatia & CMD (9714L)
11 September 2019 - 7:34PM
UK Regulatory
TIDMDPH
RNS Number : 9714L
Dechra Pharmaceuticals PLC
11 September 2019
Wednesday, 11 September 2019
Dechra officially opens its solar powered facility -
the largest integrated power plant in Croatia
This week Dechra Pharmaceuticals PLC (Dechra) has seen the
official opening of its solar powered plant at its subsidiary's
Genera d.d. (Genera) manufacturing operation in Zagreb,
Croatia.
At a cost of GBP1.3 million, which has been partially subsidised
by EU funds, the Emissary of Prime Minister of the Republic of
Croatia has announced that this is a very important solar renewable
energy project in Croatia with 5,543 photovoltaic (PV) panels being
fitted onto the existing roof structures across the Genera
site.
The facility is now recognised as the largest integrated power
plant for own consumption in Croatia. Any surplus electricity from
the power plant is distributed to the municipal electrical
grid.
The power plant project has taken seven months to complete and
was commissioned in June this year. Up until then the Genera
operation sourced 100% of energy via the main grid. Following the
installation, the annualised level of electric power generation is
expected to be approximately 1,545,000 kWh and will generate nearly
a third of the electric power needed for Dechra's Croatian
manufacturing facility.
Dechra's Chief Executive Officer Ian Page said:
"We are delighted with the outcome of this investment project
and would like to thank everyone involved including the Genera
staff, local partners, EU and government teams. This power plant
initiative will see us de-risk the site's energy supply by securing
its own source of electricity via renewable sources.
We expect to reduce the Zagreb site's CO2 footprint by
approximately 360 tonnes, which equates to 4% of the Dechra's total
CO2 emissions in 2018. We also anticipate that the power plant will
allow us to lower variable costs, mitigate the risks of electricity
price fluctuations, and will have a direct impact on reducing the
cost of goods sold in the future.
Over the next five years we will be increasing manufacturing
volume so, it is especially important from both a business and
environmental perspective to utilise a renewable and sustainable
energy source."
http://www.rns-pdf.londonstockexchange.com/rns/9714L_1-2019-9-11.pdf
Image shows: Genera d.d., Zagreb, Croatia
For further information, please contact:
Melanie Hall
Company Secretary
Telephone: +44 (0) 1606 814730
e-mail: corporate.enquiries@dechra.com
Editor's Note:
Leading the celebrations on Tuesday 10 September were, MLADEN
VEDRI President of the Supervisory Board of Genera d.d. and MARKO
FRESL, a Member of the Management Board of Genera d.d. They were
joined by Dechra's Chief Executive Officer, IAN PAGE together with
several of the Senior Executive Team and around 245 local
staff.
In addition, 80 external guests and officials joined the
celebratory day including: DOMAGOJ VALID I , Emissary of Prime
Minister of the Republic of Croatia, TOMISLAV PINTER,
Representative of Ministry of Regional Development and EU Funds,
STJEPAN KO I Mayor of Zagreb County; DARIO ZUROVEC, Mayor of Sveta
Nedjelja City, SA A KRAMAR Member of the Management Board of the
Croatian Telecom Inc.
Capital Markets Day
Dechra is hosting a Capital Markets Day for investors at the
Zagreb facility today (Wednesday 11 September). No new material
disclosures will be made during the event. Our next update to the
market will be at the Trading update at the time of the Annual
General Meeting on 18 October 2019.
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and
related products business. Its expertise is in the development,
manufacture and sales and marketing of high-quality products
exclusively for veterinarians worldwide. Dechra's business is
unique as the majority of its products are used to treat medical
conditions for which there is no other effective solution or have a
clinical or dosing advantage over competitor products. For more
information, please visit: www.dechra.com.
Stock Code: London Stock Exchange: Full Listing
(Pharmaceuticals): DPH
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
STRGCGDCIDBBGCB
(END) Dow Jones Newswires
September 11, 2019 05:34 ET (09:34 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024